However, when analyzing the relationships between MAPK4 mRNA level and the survival of cervical cancer patients after chemoradiotherapy, it was found that the survival rate of cervical cancer patients in “MAPK4 High” group was lower than that of patients in “MAPK4 Low” group (Fig. 1c). This evidence concerns the gene MAPK4 and cervical carcinoma.